Introduction
Radiation therapy is a mainstay for treatment of head and neck cancers. Radiotherapy of head and neck cancers can include the temporal bone within the field of radiation. Common radiation complications include xerostomia, eustachian tube dysfunction, chronic serous otitis media, otitis media, sinusitis, cranial nerve palsy, and osteoradionecrosis (ORN). The reported incidence of ORN after head and neck radiation is between 10 and 15%.
1 ORN of the temporal bone is an uncommon finding. A rare sequelae of ORN of the temporal bone is the development of a pseudoaneurysm of the internal carotid artery (ICA). Most published case reports of postradiation pseudoaneurysms of the ICA within the temporal bone have occurred after radiation for nasopharyngeal carcinoma. [2] [3] [4] [5] Patients with a pseudoaneurysm of the petrous ICA may present with symptoms that include hearing loss, tinnitus, and life-threatening hemorrhage.
pseudoaneurysms in this area. On evaluation in clinic, the patient gave a 2-year history of right otitis externa. He reported that minor bleeding had evolved into intermittent, unpredictable, and forceful expulsion of bright red blood from his right ear over the last several weeks. This phenomenon was witnessed in clinic when the patient was placed in the supine position. Microscopy revealed extensive bony erosion of the anterior portion of the external auditory canal (EAC) with exposure of the temporomandibular joint. The floor of the EAC was partially eroded with areas of spiculated bone. The erosion extended toward the petrous apex with a small area of exposed and palpable ICA covered with clot and granulation tissue. The tympanic membrane was thickened with obscured landmarks. A biopsy from the floor of the EAC was taken to rule out malignancy. Pathologic examination revealed acute inflammation with intraosseous bacterial invasion of the temporal bone consistent with ORN. Computed tomography (CT) of the head and temporal bones also demonstrated findings consistent with ORN and was concerning for an abnormality of the right cervicopetrous ICA (►Fig. 1). Positron emission tomography scan was also performed and did not demonstrate evidence of recurrent or metastatic head and neck cancer.
The patient was immediately admitted to the hospital and his hemoglobin was 6.4 g/dL. He subsequently underwent diagnostic cerebral angiography that identified a pseudoaneurysm of the right cervicopetrous ICA without active extravasation (►Fig. 2A). Given the history of intermittent hemorrhage and the patient's low hemoglobin, he was taken for emergent endovascular treatment.
Operation
Given the requirement for emergent management, an endovascular intervention was performed without anesthesia or sedation so that the patient's neurological status could be monitored. A baseline neurologic exam was performed and found to be without deficits prior to the procedure. A 35-minute balloon test occlusion was performed using a 4 mm Â 10 mm Hyperform balloon (ev3 Endovascular, Plymouth, Minnesota, USA) advanced over a microwire into the cervical ICA. The patient received a 5,000-unit bolus of heparin prior to balloon inflation. During this time period, the patient's neurologic status was evaluated every 5 minutes and remained deficit-free. A hypotensive challenge was performed and was also tolerated without neurologic deficits. With the balloon inflated, diagnostic angiographic runs performed in the contralateral ICA and vertebral arteries revealed adequate collateral flow. The patient was thus deemed a candidate for right ICA occlusion using detachable coils.
The balloon was deflated and withdrawn. A microcatheter was advanced into the petrous ICA. An attempt was made to deploy a single coil, but it tended to migrate intracranially. Therefore, a second microcatheter was advanced and two coils were deployed simultaneously. This produced enough radial force to seat the coils firmly in the petrous ICA. Additional coils were subsequently deployed from the cavernous ICA to the midcervical ICA, including the deployment of coils within the pseudoaneurysm sac. Throughout the procedure, the patient's neurologic status was monitored and remained stable. Once the occlusion was adequate, a final angiographic run was performed and showed adequate occlusion of the ICA without filling of the pseudoaneurysm (►Fig. 2B, ►Fig. 2C).
Postoperative Course
The patient was observed in the intensive care unit overnight. He received a transfusion of two units of packed red blood cells, which elevated his hemoglobin to 8.7 g/dL. He was progressively mobilized starting 12 hours postembolization and developed no neurologic deficits. He was transferred to the floor on postprocedure day 1 and discharged to home on postprocedure day 2.
Discussion
This case illustrates a potential solution to this unusual presentation of a postradiation pseudoaneurysm of the cervicopetrous ICA. Pseudoaneurysms are described in the literature, but there are many treatment options available. Although stent-assisted treatment may have been an option, this would have required intraprocedural and postprocedural antiplatelet therapy to prevent acute, in-stent thrombosis. Given the patient's active hemorrhage, a therapy requiring antiplatelet medications is not an ideal treatment option. Use of the two-catheter technique does have drawbacks-mainly, increasing the number of catheters in the vessel, which increases both the complexity of the case and the risk related to thrombus formation on not one but two catheters. Overall, however, the two-catheter technique was useful for this case because it eliminated the need for stenting and provided a more controlled deployment of coils within a specific area in the carotid artery that was not possible with a single catheter. The successful use of this technique allowed us to shield the patient from the risks of acute hemorrhage and in-stent thrombosis as well as the long-term risk of in-stent stenosis/thrombosis. Overall, the authors feel that the acute risk of intraprocedural thrombus with a two-catheter treatment is significantly less than the cumulative risk that the patient would have been subjected to in regards to acute hemorrhage and/or in-stent thrombosis/stenosis if he were to have received a stent-assisted treatment. 
